Pfizer Says South African Variant Could Significantly Reduce Vaccine Protection: Reuters


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • A laboratory study suggests that a COVID-19 mutant strain prevalent in South Africa may lower antibody protection from the Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) vaccine and it is not clear if the shot will be effective against the mutation, reports Reuters. Though the lab study found the vaccine was still able to neutralize the virus.
  • A two-thirds reduction in the level of neutralizing antibodies was observed, compared with vaccine effect on the most common version of the virus prevalent in U.S. trials.
  • According to an earlier preliminary study, PFE/BNTX jab was found to protect against the strains.
  • The companies said that they are still making investments and talking to regulators about developing an updated version of their mRNA vaccine or a booster shot if needed.
  • With no established benchmark yet to determine the level of antibodies needed to protect against the virus, it is unclear whether that two-thirds reduction will render the vaccine ineffective against the variant.
  • However, University of Texas Medical Branch professor and study co-author Pei-Yong Shi said he believes the Pfizer vaccine will likely be protective against the variant.
  • Moderna Inc (NASDAQ:MRNA) also said its vaccine's actual efficacy against the South African variant is yet to be determined. The company has previously reported that the vaccine was found to be effective against emerging strains.
  • Also, AstraZeneca Plc (NASDAQ: AZN) is working on a new version of its COVID-19 vaccine for immunity against the South African variant after a small early data suggested that its shot showed limited protection against the variant.
  • Price Action: BNTX slipped 2.3% at $110.9, PFE is down 0.34% at $34.78 in the premarket trading on the last check Thursday.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsFDAGeneralCOVID-19 VaccineSouth Africa